Y
Yu Yamaguchi
Researcher at National Foundation for Cancer Research
Publications - 10
Citations - 4164
Yu Yamaguchi is an academic researcher from National Foundation for Cancer Research. The author has contributed to research in topics: Decorin & Proteoglycan. The author has an hindex of 6, co-authored 10 publications receiving 4092 citations.
Papers
More filters
Journal ArticleDOI
Negative regulation of transforming growth factor-β by the proteoglycan decorin
TL;DR: The ability of decorin to bind transforming growth factor-β, an autocrine factor that stimulates the growth of Chinese hamster ovary cells, is reported, suggesting that decorin may be a component of a feedback system regulating cell growth.
Journal ArticleDOI
Proteoglycans as modulators of growth factor activities
Erkki Ruoslahti,Yu Yamaguchi +1 more
TL;DR: Proteoglycans bind to extracellular proteins such as fibronectin and are found to be binders of many growth factors.
Journal ArticleDOI
Natural inhibitor of transforming growth factor-|[beta]| protects against scarring in experimental kidney disease
Wayne A. Border,Nancy A. Noble,Tatsuo Yamamoto,John R. Harper,Yu Yamaguchi,Michael D. Pierschbacher,Erkki Ruoslahti +6 more
TL;DR: It is reported here that administration of decorin inhibits the increased production of extracellular matrix and attenuates manifestations of disease, confirming the hypothesis that decorin may eventually prove to be clinically useful in diseases associated with overproduction of TGF-β.
Journal ArticleDOI
Expression of human proteoglycan in Chinese hamster ovary cells inhibits cell proliferation.
Yu Yamaguchi,Erkki Ruoslahti +1 more
TL;DR: Chinese hamster ovary cell lines expressing human decorin from a stably transfected complementary DNA construct form a more orderly monolayer and grow to a lower saturation density than control cells lacking decorin, revealing a novel growth inhibitory mechanism which may be related to contact inhibition of cell proliferation.
Patent
Inhibitors of cell regulatory factors
Erkki I. Ruoslahti,Yu Yamaguchi +1 more
TL;DR: In this paper, a method of inhibiting an activity of a cell regulatory factor comprising contacting the cell regulatory factors with a purified polypeptide, wherein the polyPEptide comprises the cell-regulatory factor binding domain of a protein and wherein the protein is characterized by a leucine-rich repeat of about 24 amino acids.